Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.
A potent class of anticancer, human farnesyltransferase (hFTase) inhibitors has been identified by "piggy-backing" on potent, antimalarial inhibitors of Plasmodium falciparum farnesyltransferase (PfFTase). On the basis of a 4-fold substituted ethylenediamine scaffold, the inhibitors are st...
Main Authors: | Fletcher, S, Keaney, E, Cummings, C, Blaskovich, M, Hast, M, Glenn, M, Chang, S, Bucher, C, Floyd, R, Katt, W, Gelb, M, Van Voorhis, W, Beese, L, Sebti, S, Hamilton, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.
by: Hast, M, et al.
Published: (2009) -
Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validation.
by: Fletcher, S, et al.
Published: (2008) -
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
by: Gajewski Thomas F, et al.
Published: (2012-12-01) -
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
by: Van Voorhis, W, et al.
Published: (2007) -
Farnesyltransferase inhibitors.
by: Hahn, S, et al.
Published: (2001)